Showing results (711-720 of 723) with videos related to
Sort By:
Pageof 73
Neurology|October 24, 2019
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial dataMyla D Goldman, Nicholas G LaRocca, Richard A Rudick, et al.American Journal of Respiratory and Critical Care Medicine|April 1, 1997
Bovine surfactant therapy for patients with acute respiratory distress syndromeT J Gregory, K P Steinberg, R Spragg, et al.The Journal of Biological Chemistry|April 19, 2014
Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J miceEven Fjære, Ulrike L Aune, Kristin Røen, et al.The Journal of Physiology|November 30, 1999
Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imagingM F James, M I Smith, K H Bockhorst, et al.Cancer Cell|July 2, 2021
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerAlfredo Addeo, Pankil K Shah, Natacha Bordry, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|October 4, 2011
Evidence-based recommendations for negative pressure wound therapy: treatment variables (pressure levels, wound filler and contact layer)--steps towards an international consensusH Birke-Sorensen, M Malmsjo, P Rome, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2017
Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistanceJulia M Houthuijzen, Ilse Oosterom, Brian D Hudson, et al.Injury|February 15, 2011
Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensusE Krug, L Berg, C Lee, et al.Journal of Tissue Viability|November 29, 2011
Evidence-based recommendations for the use of negative pressure wound therapy in chronic wounds: steps towards an international consensusS Vig, C Dowsett, L Berg, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2017
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disabilityNicholas G LaRocca, Lynn D Hudson, Richard Rudick, et al.Pageof 73